In summary, we showed that YTHDF2 deficiency inhibited lung cancer cell proliferation and migration by modulating m6A levels of AXIN1, and impeding the activation of Wnt/β-catenin signaling. The gene discussed is AXIN1; the disease is lung carcinoma.